We guide BioPharma companies through developing expanded access strategies up to full EAP execution and preparation for full commercial launch. We have experience in a wide range of expanded access use cases, across different regions and therapeutics areas:
Conducting expanded access programs on behalf of our clients is our core expertise. Our team of experts handles areas such as Regulatory, Quality, Site Management, Supply Chain, Real-World Data, and Pharmacovigilance.
Adrianne Rivard
14 Jul 2026
8 mins read
Theo Cantero
29 Jun 2026
10 mins read
myTomorrows Team
26 May 2026
4 mins read
Dennis Akkaya
26 May 2026
8 mins read
Andrea Enguita
20 May 2026
13 mins read
Andrea Enguita
19 May 2026
37 mins read
Andrea Enguita
20 Apr 2026
12 mins read
myTomorrows Team
16 Apr 2026
4 mins read
Stephanie Ferket
15 Apr 2026
15 mins read
myTomorrows Team
26 Mar 2026
5 mins read